Literature DB >> 17470720

Personalized medicine for high blood pressure.

Stephen T Turner, Gary L Schwartz, Eric Boerwinkle.   

Abstract

Mesh：

Year:  2007        PMID： 17470720      PMCID： PMC5012173          DOI： 10.1161/HYPERTENSIONAHA.107.087049

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  25 in total

1.  Shattuck lecture--medical and societal consequences of the Human Genome Project.

Authors:  F S Collins
Journal:  N Engl J Med       Date:  1999-07-01       Impact factor: 91.245

2.  A haplotype map of the human genome.

Authors: 
Journal:  Nature       Date:  2005-10-27       Impact factor: 49.962

3.  The incidentalome: a threat to genomic medicine.

Authors:  Isaac S Kohane; Daniel R Masys; Russ B Altman
Journal:  JAMA       Date:  2006-07-12       Impact factor: 56.272

4.  Systems analysis of arterial pressure regulation and hypertension.

Authors:  A C Guyton; T G Coleman; A W Cowley; J F Liard; R A Norman; R D Manning
Journal:  Ann Biomed Eng       Date:  1972-12       Impact factor: 3.934

5.  Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles.

Authors:  J H Laragh
Journal:  Am J Med       Date:  1973-09       Impact factor: 4.965

Review 6.  Circulation: overall regulation.

Authors:  A C Guyton; T G Coleman; H J Granger
Journal:  Annu Rev Physiol       Date:  1972       Impact factor: 19.318

7.  Essential hypertension: renin and aldosterone, heart attack and stroke.

Authors:  H R Brunner; J H Laragh; L Baer; M A Newton; F T Goodwin; L R Krakoff; R H Bard; F R Bühler
Journal:  N Engl J Med       Date:  1972-03-02       Impact factor: 91.245

8.  Interacting effects of gender and genotype on blood pressure response to hydrochlorothiazide.

Authors:  Gary L Schwartz; Stephen T Turner; Arlene B Chapman; Eric Boerwinkle
Journal:  Kidney Int       Date:  2002-11       Impact factor: 10.612

9.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

10.  Multilocus effects of the renin-angiotensin-aldosterone system genes on blood pressure response to a thiazide diuretic.

Authors:  L Frazier; S T Turner; G L Schwartz; A B Chapman; E Boerwinkle
Journal:  Pharmacogenomics J       Date:  2004       Impact factor: 3.550
View more
  8 in total

Review 1.  Personalized vascular medicine: individualizing drug therapy.

Authors:  Emil M Degoma; Giovanni Rivera; Scott M Lilly; M Haris U Usman; Emile R Mohler
Journal:  Vasc Med       Date:  2011-10       Impact factor: 3.239

2.  Characteristics associated with informed consent for genetic studies in the ACCORD trial.

Authors:  Denise G Simons-Morton; Jeffrey C Chan; Angela R Kimel; Peter E Linz; Cynthia L Stowe; John Summerson; Walter T Ambrosius
Journal:  Contemp Clin Trials       Date:  2013-12-17       Impact factor: 2.226

3.  A comparison of the genetic and clinical profile of men that respond and do not respond to the immediate antihypertensive effects of aerobic exercise.

Authors:  Linda S Pescatello; Bruce E Blanchard; Gregory J Tsongalis; Ann A O'Connell; Heather Gordish-Dressman; Carl M Maresh; Paul D Thompson
Journal:  Appl Clin Genet       Date:  2008-09-18

4.  Genomic association analysis suggests chromosome 12 locus influencing antihypertensive response to thiazide diuretic.

Authors:  Stephen T Turner; Kent R Bailey; Brooke L Fridley; Arlene B Chapman; Gary L Schwartz; High Seng Chai; Hugues Sicotte; Jean-Pierre Kocher; Andréi S Rodin; Eric Boerwinkle
Journal:  Hypertension       Date:  2008-06-30       Impact factor: 10.190

5.  Power to identify a genetic predictor of antihypertensive drug response using different methods to measure blood pressure response.

Authors:  Stephen T Turner; Gary L Schwartz; Arlene B Chapman; Amber L Beitelshees; John G Gums; Rhonda M Cooper-Dehoff; Eric Boerwinkle; Julie A Johnson; Kent R Bailey
Journal:  J Transl Med       Date:  2012-03-13       Impact factor: 5.531

Review 6.  Personalized medicine and treatment approaches in hypertension: current perspectives.

Authors:  James Brian Byrd
Journal:  Integr Blood Press Control       Date:  2016-04-06

7.  Identifying drug-related attributes to personalise antihypertensive agents: the outcome report of patients receiving metoprolol therapy.

Authors:  Chunyu Liu; Jing Xu; Ran Liu; Miye Wang; Yixuan Zhuo; Lan Su; Hongmei Yan; Qing Zhang
Journal:  BMC Med Inform Decis Mak       Date:  2021-12-30       Impact factor: 2.796

Review 8.  Why do hypertensive patients of African ancestry respond better to calcium blockers and diuretics than to ACE inhibitors and β-adrenergic blockers? A systematic review.

Authors:  Lizzy M Brewster; Yackoob K Seedat
Journal:  BMC Med       Date:  2013-05-30       Impact factor: 8.775
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.